 | • レポートコード：QYR9ST04805 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、拡張型心筋症治療の世界市場について調査・分析し、拡張型心筋症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物、植込み型デバイス）、用途別（病院および診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の拡張型心筋症治療市場動向 ・主要企業別マーケットシェア ・拡張型心筋症治療の種類別市場規模2014-2019 （薬物、植込み型デバイス） ・拡張型心筋症治療の用途別市場規模2014-2019 （病院および診療所、その他） ・拡張型心筋症治療の北米市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療の中国市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療のインド市場：主要企業・種類別/用途別市場規模 ・拡張型心筋症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Pfizer、Novartis、Merck、Janssen Pharmaceuticals、AstraZeneca、Array BioPharma、Vericel、Celladon、Teva Pharmaceutical Industries） ・拡張型心筋症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Dilated Cardiomyopathy (DCM) is a condition in which heart’s left ventricle, is enlarged and weakened and the ability to pump blood is decreased.The growth in DCM treatment market is due to prominent rise in number of heart failure patients worldwide over the years, R&D activities and increased awareness for timely diagnosis.
In 2018, the global Dilated Cardiomyopathy Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dilated Cardiomyopathy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dilated Cardiomyopathy Treatment development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Pfizer
Novartis
Merck
Janssen Pharmaceuticals
AstraZeneca
Array BioPharma
Vericel
Celladon
Teva Pharmaceutical Industries
Market segment by Type, the product can be split into
Drugs
Implantable Devices
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Dilated Cardiomyopathy Treatment status, future forecast, growth opportunity, key market and key players.
To present the Dilated Cardiomyopathy Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dilated Cardiomyopathy Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dilated Cardiomyopathy Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drugs
1.4.3 Implantable Devices
1.5 Market by Application
1.5.1 Global Dilated Cardiomyopathy Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Dilated Cardiomyopathy Treatment Market Size
2.2 Dilated Cardiomyopathy Treatment Growth Trends by Regions
2.2.1 Dilated Cardiomyopathy Treatment Market Size by Regions (2014-2025)
2.2.2 Dilated Cardiomyopathy Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Dilated Cardiomyopathy Treatment Market Size by Manufacturers
3.1.1 Global Dilated Cardiomyopathy Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Dilated Cardiomyopathy Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dilated Cardiomyopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Dilated Cardiomyopathy Treatment Key Players Head office and Area Served
3.3 Key Players Dilated Cardiomyopathy Treatment Product/Solution/Service
3.4 Date of Enter into Dilated Cardiomyopathy Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019)
4.2 Global Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Dilated Cardiomyopathy Treatment Market Size (2014-2019)
5.2 Dilated Cardiomyopathy Treatment Key Players in United States
5.3 United States Dilated Cardiomyopathy Treatment Market Size by Type
5.4 United States Dilated Cardiomyopathy Treatment Market Size by Application
6 Europe
6.1 Europe Dilated Cardiomyopathy Treatment Market Size (2014-2019)
6.2 Dilated Cardiomyopathy Treatment Key Players in Europe
6.3 Europe Dilated Cardiomyopathy Treatment Market Size by Type
6.4 Europe Dilated Cardiomyopathy Treatment Market Size by Application
7 China
7.1 China Dilated Cardiomyopathy Treatment Market Size (2014-2019)
7.2 Dilated Cardiomyopathy Treatment Key Players in China
7.3 China Dilated Cardiomyopathy Treatment Market Size by Type
7.4 China Dilated Cardiomyopathy Treatment Market Size by Application
8 Japan
8.1 Japan Dilated Cardiomyopathy Treatment Market Size (2014-2019)
8.2 Dilated Cardiomyopathy Treatment Key Players in Japan
8.3 Japan Dilated Cardiomyopathy Treatment Market Size by Type
8.4 Japan Dilated Cardiomyopathy Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Dilated Cardiomyopathy Treatment Market Size (2014-2019)
9.2 Dilated Cardiomyopathy Treatment Key Players in Southeast Asia
9.3 Southeast Asia Dilated Cardiomyopathy Treatment Market Size by Type
9.4 Southeast Asia Dilated Cardiomyopathy Treatment Market Size by Application
10 India
10.1 India Dilated Cardiomyopathy Treatment Market Size (2014-2019)
10.2 Dilated Cardiomyopathy Treatment Key Players in India
10.3 India Dilated Cardiomyopathy Treatment Market Size by Type
10.4 India Dilated Cardiomyopathy Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Dilated Cardiomyopathy Treatment Market Size (2014-2019)
11.2 Dilated Cardiomyopathy Treatment Key Players in Central & South America
11.3 Central & South America Dilated Cardiomyopathy Treatment Market Size by Type
11.4 Central & South America Dilated Cardiomyopathy Treatment Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dilated Cardiomyopathy Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dilated Cardiomyopathy Treatment Introduction
12.2.4 Pfizer Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dilated Cardiomyopathy Treatment Introduction
12.3.4 Novartis Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dilated Cardiomyopathy Treatment Introduction
12.4.4 Merck Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dilated Cardiomyopathy Treatment Introduction
12.5.4 Janssen Pharmaceuticals Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.5.5 Janssen Pharmaceuticals Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dilated Cardiomyopathy Treatment Introduction
12.6.4 AstraZeneca Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Array BioPharma
12.7.1 Array BioPharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dilated Cardiomyopathy Treatment Introduction
12.7.4 Array BioPharma Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.7.5 Array BioPharma Recent Development
12.8 Vericel
12.8.1 Vericel Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dilated Cardiomyopathy Treatment Introduction
12.8.4 Vericel Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.8.5 Vericel Recent Development
12.9 Celladon
12.9.1 Celladon Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dilated Cardiomyopathy Treatment Introduction
12.9.4 Celladon Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.9.5 Celladon Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dilated Cardiomyopathy Treatment Introduction
12.10.4 Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)
12.10.5 Teva Pharmaceutical Industries Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Dilated Cardiomyopathy Treatment Key Market Segments
Table Key Players Dilated Cardiomyopathy Treatment Covered
Table Global Dilated Cardiomyopathy Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dilated Cardiomyopathy Treatment Market Size Market Share by Type 2014-2025
Figure Drugs Figures
Table Key Players of Drugs
Figure Implantable Devices Figures
Table Key Players of Implantable Devices
Table Global Dilated Cardiomyopathy Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Dilated Cardiomyopathy Treatment Report Years Considered
Table Global Dilated Cardiomyopathy Treatment Market Size 2014-2025 (Million US$)
Figure Global Dilated Cardiomyopathy Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dilated Cardiomyopathy Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Dilated Cardiomyopathy Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Dilated Cardiomyopathy Treatment Market Share by Regions 2014-2019
Figure Global Dilated Cardiomyopathy Treatment Market Share by Regions 2014-2019
Figure Global Dilated Cardiomyopathy Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Dilated Cardiomyopathy Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Treatment Market Share by Manufacturers (2014-2019)
Figure Global Dilated Cardiomyopathy Treatment Market Share by Manufacturers in 2018
Table Global Dilated Cardiomyopathy Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dilated Cardiomyopathy Treatment Product/Solution/Service
Table Date of Enter into Dilated Cardiomyopathy Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Treatment Market Size Share by Type (2014-2019)
Figure Global Dilated Cardiomyopathy Treatment Market Size Market Share by Type (2014-2019)
Table Global Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Dilated Cardiomyopathy Treatment Market Size Share by Application (2014-2019)
Figure Global Dilated Cardiomyopathy Treatment Market Size Market Share by Application (2014-2019)
Figure Global Dilated Cardiomyopathy Treatment Revenue Market Share by Application in 2018
Figure United States Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table United States Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table United States Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Figure Europe Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table Europe Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table Europe Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Figure China Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table China Dilated Cardiomyopathy Treatment Market Size by Type (2014-20189) (Million US$)
Table China Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table China Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table China Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Figure Japan Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table Japan Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table Japan Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table Southeast Asia Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table Southeast Asia Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Figure India Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table India Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table India Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table India Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table India Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Figure Central & South America Dilated Cardiomyopathy Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dilated Cardiomyopathy Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dilated Cardiomyopathy Treatment Market Share (2018-2019)
Table Central & South America Dilated Cardiomyopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dilated Cardiomyopathy Treatment Market Share by Type (2014-2019)
Table Central & South America Dilated Cardiomyopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dilated Cardiomyopathy Treatment Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Merck Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Array BioPharma Company Details
Table Array BioPharma Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Array BioPharma Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Array BioPharma Recent Development
Table Vericel Company Details
Table Vericel Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Vericel Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Vericel Recent Development
Table Celladon Company Details
Table Celladon Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Celladon Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Celladon Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Global Dilated Cardiomyopathy Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Dilated Cardiomyopathy Treatment Market Size Share by Regions (2019-2025)
Figure Global Dilated Cardiomyopathy Treatment Market Size Share by Regions in 2025
Figure United States Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dilated Cardiomyopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Dilated Cardiomyopathy Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Dilated Cardiomyopathy Treatment Market Size by Product (2019-2025)
Figure Global Dilated Cardiomyopathy Treatment Market Size by Product in 2025
Table Global Dilated Cardiomyopathy Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Dilated Cardiomyopathy Treatment Market Size by Application (2019-2025)
Figure Global Dilated Cardiomyopathy Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
拡張型心筋症治療薬の世界市場：市場規模・現状・予測 Dilated cardiomyopathy (DCM) is characterized by LV (left ventricular) or biventricular systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary artery disease.In 2018, the global Dilated Cardiomyopathy Therapeutic market size was xx million US$ and it is expected …- 心筋症の世界市場：市場規模・現状・予測 Cardiomyopathy refers to diseases of the heart muscleThe major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of …
- 肥大型心筋症治療薬の世界市場：市場規模・現状・予測 HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
- ドライアイ薬およびデバイス治療の世界市場：市場規模・現状・予測 Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …